Target Gene/Pathway Pathway / Gene
Search results
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID |
---|---|---|---|---|---|
1 | Allograft rejection 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IL5 [1] IL5 💬
|
Mepolizumab Mepolizumab 💬
| Mepolizumab | 044 [4] 44, 45, 98, 162 💬
|
2 | Allograft rejection 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IL5 [1] IL5 💬
|
Reslizumab Reslizumab 💬
| Reslizumab | 044 [2] 44, 98 💬
|
3 | Asthma 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IL5 [1] IL5 💬
|
Mepolizumab Mepolizumab 💬
| Mepolizumab | 044 [4] 44, 45, 98, 162 💬
|
4 | Asthma 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IL5 [1] IL5 💬
|
Reslizumab Reslizumab 💬
| Reslizumab | 044 [2] 44, 98 💬
|
5 | Autoimmune thyroid disease 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IL5 [1] IL5 💬
|
Mepolizumab Mepolizumab 💬
| Mepolizumab | 044 [4] 44, 45, 98, 162 💬
|
6 | Autoimmune thyroid disease 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IL5 [1] IL5 💬
|
Reslizumab Reslizumab 💬
| Reslizumab | 044 [2] 44, 98 💬
|
7 | Cytokine-cytokine receptor interaction 💬 2 genes, 3 drugs (DrugBank) and 5 diseases |
IL5 [1] IL5 💬
|
Mepolizumab Mepolizumab 💬
| Mepolizumab | 044 [4] 44, 45, 98, 162 💬
|
8 | Cytokine-cytokine receptor interaction 💬 2 genes, 3 drugs (DrugBank) and 5 diseases |
IL5 [1] IL5 💬
|
Reslizumab Reslizumab 💬
| Reslizumab | 044 [2] 44, 98 💬
|
9 | Cytokine-cytokine receptor interaction 💬 2 genes, 3 drugs (DrugBank) and 5 diseases |
IL5RA [1] IL5RA 💬
|
Benralizumab Benralizumab 💬
| Benralizumab | 044 [5] 44, 45, 98, 162, 299 💬
|
10 | Fc epsilon RI signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IL5 [1] IL5 💬
|
Mepolizumab Mepolizumab 💬
| Mepolizumab | 044 [4] 44, 45, 98, 162 💬
|
11 | Fc epsilon RI signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IL5 [1] IL5 💬
|
Reslizumab Reslizumab 💬
| Reslizumab | 044 [2] 44, 98 💬
|
12 | Hematopoietic cell lineage 💬 2 genes, 3 drugs (DrugBank) and 5 diseases |
IL5 [1] IL5 💬
|
Mepolizumab Mepolizumab 💬
| Mepolizumab | 044 [4] 44, 45, 98, 162 💬
|
13 | Hematopoietic cell lineage 💬 2 genes, 3 drugs (DrugBank) and 5 diseases |
IL5 [1] IL5 💬
|
Reslizumab Reslizumab 💬
| Reslizumab | 044 [2] 44, 98 💬
|
14 | Hematopoietic cell lineage 💬 2 genes, 3 drugs (DrugBank) and 5 diseases |
IL5RA [1] IL5RA 💬
|
Benralizumab Benralizumab 💬
| Benralizumab | 044 [5] 44, 45, 98, 162, 299 💬
|
15 | IL-17 signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IL5 [1] IL5 💬
|
Mepolizumab Mepolizumab 💬
| Mepolizumab | 044 [4] 44, 45, 98, 162 💬
|
16 | IL-17 signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IL5 [1] IL5 💬
|
Reslizumab Reslizumab 💬
| Reslizumab | 044 [2] 44, 98 💬
|
17 | Inflammatory bowel disease 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IL5 [1] IL5 💬
|
Mepolizumab Mepolizumab 💬
| Mepolizumab | 044 [4] 44, 45, 98, 162 💬
|
18 | Inflammatory bowel disease 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IL5 [1] IL5 💬
|
Reslizumab Reslizumab 💬
| Reslizumab | 044 [2] 44, 98 💬
|
19 | Intestinal immune network for IgA production 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IL5 [1] IL5 💬
|
Mepolizumab Mepolizumab 💬
| Mepolizumab | 044 [4] 44, 45, 98, 162 💬
|
20 | Intestinal immune network for IgA production 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IL5 [1] IL5 💬
|
Reslizumab Reslizumab 💬
| Reslizumab | 044 [2] 44, 98 💬
|
21 | JAK-STAT signaling pathway 💬 2 genes, 3 drugs (DrugBank) and 5 diseases |
IL5 [1] IL5 💬
|
Mepolizumab Mepolizumab 💬
| Mepolizumab | 044 [4] 44, 45, 98, 162 💬
|
22 | JAK-STAT signaling pathway 💬 2 genes, 3 drugs (DrugBank) and 5 diseases |
IL5 [1] IL5 💬
|
Reslizumab Reslizumab 💬
| Reslizumab | 044 [2] 44, 98 💬
|
23 | JAK-STAT signaling pathway 💬 2 genes, 3 drugs (DrugBank) and 5 diseases |
IL5RA [1] IL5RA 💬
|
Benralizumab Benralizumab 💬
| Benralizumab | 044 [5] 44, 45, 98, 162, 299 💬
|
24 | Pathways in cancer 💬 2 genes, 3 drugs (DrugBank) and 5 diseases |
IL5 [1] IL5 💬
|
Mepolizumab Mepolizumab 💬
| Mepolizumab | 044 [4] 44, 45, 98, 162 💬
|
25 | Pathways in cancer 💬 2 genes, 3 drugs (DrugBank) and 5 diseases |
IL5 [1] IL5 💬
|
Reslizumab Reslizumab 💬
| Reslizumab | 044 [2] 44, 98 💬
|
26 | Pathways in cancer 💬 2 genes, 3 drugs (DrugBank) and 5 diseases |
IL5RA [1] IL5RA 💬
|
Benralizumab Benralizumab 💬
| Benralizumab | 044 [5] 44, 45, 98, 162, 299 💬
|
27 | T cell receptor signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IL5 [1] IL5 💬
|
Mepolizumab Mepolizumab 💬
| Mepolizumab | 044 [4] 44, 45, 98, 162 💬
|
28 | T cell receptor signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IL5 [1] IL5 💬
|
Reslizumab Reslizumab 💬
| Reslizumab | 044 [2] 44, 98 💬
|
29 | Th1 and Th2 cell differentiation 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IL5 [1] IL5 💬
|
Mepolizumab Mepolizumab 💬
| Mepolizumab | 044 [4] 44, 45, 98, 162 💬
|
30 | Th1 and Th2 cell differentiation 💬 1 gene, 2 drugs (DrugBank) and 4 diseases |
IL5 [1] IL5 💬
|
Reslizumab Reslizumab 💬
| Reslizumab | 044 [2] 44, 98 💬
|